The Role of the Journal of Psychedelic Drugs in the Evolution of Psychedelic Medicine.
Journal of Psychoactive Drugs January 1, 2019 DOI: 10.1080/02791072.2019.1589607 (opens in new tab) via PubMed
Summary
AI-generated from the abstractThis review describes the central role that this journal, and its founder Dr. David Smith, has played in documenting the second wave of psychedelic research. As modern culture enters a third wave of the psychedelic revival, the journal has witnessed and supported research exploring the therapeutic uses of psychedelics. The article traces this historical trajectory, highlighting how the journal has served as a key platform for scholarship on psychedelic medicine and therapy across these eras.
Study at a glance
| Characteristics | Historical analysis Peer reviewed |
|---|---|
| Topics | LSD |
| Keywords | History Journal Psychedelic Third wave |
| Citations | 3 |
| Key finding | Argues that the journal and Dr. David Smith have been central in bearing witness to the second wave of psychedelic research and the current third wave of the psychedelic revival, which explores therapeutic uses. |
Abstract
A review of the primary role that this journal (and by extension, Dr. David Smith) has played in bearing witness to the second wave of psychedelic research as our modern-day culture embraces the current third wave of the psychedelic revival, exploring through research its therapeutic uses.